Santa Cruz Biotechnology features a diverse variety of STRO-1 monoclonal antibodies for research in stem cell biology and regenerative medicine. STRO-1 monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). STRO-1 is a well-characterized marker for mesenchymal stem cells, playing a crucial role in the identification and isolation of stem cells from various tissues. Its significance extends to studies on tissue regeneration, cell differentiation, and the development of stem cell therapies. Understanding STRO-1 function is essential for advancing research in cellular therapies and regenerative medicine. STRO-1 monoclonal antibodies enable precise detection and characterization of mesenchymal stem cells across diverse experimental conditions. Researchers can leverage STRO-1 monoclonal antibodies to investigate stem cell properties, differentiation potential, and therapeutic applications. STRO-1 monoclonal antibodies from Santa Cruz Biotechnology contribute to advancing stem cell research and therapeutic development within the scientific community.